Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, January 31, 2015
 
Register | Sign in
Home Page>Products
  Product News
TAdvanced Thermal Cycler with Silver Block
Saturday, January 31, 2015
Highest speed and reproducibility for ultimate PCR performance.

ProImmune Introduces ProM2™ Human Class II MHC Monomer Reagents
Friday, January 30, 2015
Enabling proven tetramer analysis for detecting single antigen-specific T cells.

Hepregen Launches First Dog HepatoPac® Assay Kit
Friday, January 30, 2015
Application-directed kit complements human, rat and monkey counterparts.

Premium Glass Refractive Index Measurements with CRAIC Technologies
Friday, January 30, 2015
rIQ™ from CRAIC Technologies is designed to help the forensic scientist measure the refractive index of glass quickly, accurately and easily using the ASTM E1967 methodology.

Shimadzu Launches Nexera UC
Thursday, January 29, 2015
Nexera Unified Chromatography system showcases complete automation and combines automatic sample pre-treatment with chromatographic separation and analysis.

Hiden Gas Analyzers at Pittcon 2015
Thursday, January 29, 2015
Company will feature their latest QGA systems for direct real time analysis at Pittcon 2015.

Bringing Customers a New Web Experience - Alfa Aesar Launches Redesigned Website
Thursday, January 29, 2015
The redesign provides a fresh new layout and offers improved intuitive navigation with a high degree of user-friendliness.

Promega PowerPlex® Fusion 6C System Launched
Thursday, January 29, 2015
The system improves mixture interpretation with difficult forensic casework samples.

Analytik Announces the Launch of the Sentronic Handheld NIR Analyzer
Wednesday, January 28, 2015
SentroID for the fast identification and composition analysis of plastics and polymers.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 10846
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn